1. Home
  2. Stocks
  3. Astec Share Price

Astec Lifesciences Share Price

Agro-Chemicals Small Cap

₹1,076.60 -3.25 (-0.3%)

05 Nov, 2024 21:50

SIP TrendupStart SIP in ASTEC

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹1,070
  • High
  • ₹1,090
  • 52 Week Low
  • ₹825
  • 52 Week High
  • ₹1,474
  • Open Price₹1,082
  • Previous Close₹1,080
  • Volume33,825

Investment Returns

  • Over 1 Month -5.18%
  • Over 3 Month -11.24%
  • Over 6 Month -12.62%
  • Over 1 Year -15.36%
SIP Lightning

Smart Investing Starts Here Start SIP with Astec Lifesciences for Steady Growth!

Astec Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -20.4
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 2,111
  • P/B Ratio
  • 5.7
  • Average True Range
  • 35.65
  • EPS
  • -23.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -27.63
  • RSI
  • 42.75
  • MFI
  • 31.13

Astec Lifesciences Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations98.5569.37153.7550.79110.79
Total Income From Operations98.5569.37153.7550.79110.79
P/L Before Interest, Excpt. Items & Tax-29.24-54.625.72-26.15-11.64
P/L Before Exceptional Items & Tax-38.57-61.67-0.96-32.25-17.64
P/L After Tax from Ordinary Activities-38.57-39.74-0.99-24.35-13.45
Net Profit/Loss For the Period-38.57-39.74-0.99-24.35-13.45
IndicatorMar 24Mar 23
Revenue From Operations [Gross]457.70628.17
Revenue From Operations [Net]457.70628.17
Total Operating Revenues458.18628.17
Total Revenue463.76641.20
Total Expenses525.64606.35
Profit/Loss Before Tax-61.8834.85
Profit/Loss For The Period-46.9925.52
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity10.1374.32
Net Cash Used In Investing Activity-134.98-112.07
Net Cash Used in Finance Activity124.8537.66
Net Inc/Dec In Cash And Equivalent0.00-0.09
Cash And Equivalent End Of Year0.460.46
IndicatorMar 24Mar 23
Total Share Capital19.6119.61
Total Non-Current Liabilities208.2233.73
Total Current Liabilities397.25526.33
Total Capital And Liabilities974.15978.85
Total Non-Current Assets576.67480.75
Total Current Assets397.48498.09
Total Assets974.15978.85
Indicator20242023
EBIT Margin (%)-7.998.84
Return On Capital Employed (%)-6.3412.28
Return On Equity (%)-12.746.09
Long Term Debt To Equity (%)53.972.59
Book Value/Share (INR)188.01213.61
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations98.5569.37153.7550.79110.79
Total Income From Operations98.5569.37153.7550.79110.79
P/L Before Interest, Excpt. Items & Tax-29.21-54.605.75-26.12-11.60
P/L Before Exceptional Items & Tax-38.54-61.64-0.93-32.22-17.60
P/L After Tax from Ordinary Activities-38.55-39.72-0.96-24.33-13.42
Net Profit/Loss For the Period-38.55-39.72-0.96-24.33-13.42
IndicatorMar 24Mar 23
Revenue From Operations [Gross]457.70628.17
Revenue From Operations [Net]457.70628.17
Total Operating Revenues458.18628.17
Total Revenue463.82641.23
Total Expenses525.57606.28
Profit/Loss Before Tax-61.7534.95
Profit/Loss For The Period-46.8925.59
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity10.2274.66
Net Cash Used In Investing Activity-135.18-112.51
Net Cash Used in Finance Activity124.9637.77
Net Inc/Dec In Cash And Equivalent0.00-0.08
Cash And Equivalent End Of Year0.470.47
IndicatorMar 24Mar 23
Total Share Capital19.6119.61
Total Non-Current Liabilities208.2533.66
Total Current Liabilities397.16526.20
Total Capital And Liabilities974.93979.41
Total Non-Current Assets576.44480.56
Total Current Assets398.49498.85
Total Assets974.93979.41
Indicator20242023
EBIT Margin (%)-7.978.86
Return On Capital Employed (%)-6.3212.28
Return On Equity (%)-12.706.09
Long Term Debt To Equity (%)53.882.59
Book Value/Share (INR)188.44214.00

Astec Lifesciences Technicals

EMA & SMA

Current Price
₹1,076.60
-3.25 (-0.3%)
pointer
  • stock-down_img
  • Bullish Moving Average 1
  • stock-up_img
  • Bearish Moving Average 15
  • 20 Day
  • ₹1,093.09
  • 50 Day
  • ₹1,137.67
  • 100 Day
  • ₹1,167.67
  • 200 Day
  • ₹1,189.07

Resistance and Support

1078.68 Pivot Speed
  • R3 1,108.32
  • R2 1,099.13
  • R1 1,087.87
  • S1 1,067.42
  • S2 1,058.23
  • S3 1,046.97

Is Astec Lifesciences Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Astec Lifesciences Ltd. manufactures agrochemical products, including fungicides, herbicides, and intermediates. With advanced production facilities in India, it serves agricultural sectors globally, offering high-quality crop protection solutions to enhance farm productivity and sustainability. Astec Lifesciences has an operating revenue of Rs. 372.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of -13% needs improvement, ROE of -12% is poor and needs improvement. The company has a debt to equity of 54%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 42 indicates it belongs to a fair industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Astec Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-25 Quarterly Results
2024-07-29 Quarterly Results
2024-05-02 Audited Results
2024-01-25 Quarterly Results
2023-10-27 Quarterly Results & Others

Astec Lifesciences F&O

Astec Lifesciences Shareholding Pattern

66.75%
4%
0.53%
0%
21.94%
6.78%
  • NSE Symbol
  • ASTEC
  • BSE Symbol
  • 533138
  • ISIN
  • INE563J01010

Astec Lifesciences FAQs

Astec Lifesciences share price is ₹1,076 As on 05 November, 2024 | 21:36

The Market Cap of Astec Lifesciences is ₹2111.4 Cr As on 05 November, 2024 | 21:36

The P/E ratio of Astec Lifesciences is -20.4 As on 05 November, 2024 | 21:36

The PB ratio of Astec Lifesciences is 5.7 As on 05 November, 2024 | 21:36

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.